Recent studies revealed that EGFR/ALK-positive NSCLC was significantly associated with the immunosuppressive environment and deficient CD8+ tissue-resident memory cells, contributing to the low efficacy of ICIs plus TKIs, and how to reverse the immunosuppressive phenotype would be a critical challenge [124,125]. This evidence concerns the gene ALK and non-small cell lung carcinoma.